Castor EDC

Castor is the top-rated Electronic Data Capture (EDC) system. Castor's EDC, eConsent, ePRO, eCOA, Dig

Based in the United States and The Netherlands, Castor is an international health-tech company founded by CEO Derk Arts, MD, PhD. Castor's EDC, ePRO, eCOA, Digital Enrollment, eConsent, eSource, and eTMF solutions enable researchers to easily capture and integrate data from any source and decentralize their trials. More than 65,000 researchers across 90 countries are using Castor and the platform has supported more than 4,000 commercial and academic studies. These studies cover a broad range of therapeutic areas including diabetes, cardiovascular disease, rare diseases, infectious diseases, and oncology. Researchers on the platform generate vast amounts of data from traditional and remote trials, and Castor recently reached milestones of 250,000,000 data points and 2,200,000 enrolled patients. Castor’s goal is to make the world’s research data reusable, enabling AI-driven clinical trials, and ultimately creating a future in which they maximize the impact of data through reuse.

26/10/2021

At Castor EDC, we recently donated equipment and after a careful selection process, we selected Stichting JAVEA Nepal, a small non-profit organization in the south of the Netherlands, founded to improve the lives of children in the Nepalese' mountainside. It provides financial support & on-the-ground assistance for building and maintaining a medical post in the rural mountains and supporting a local girls school with learning materials and salaries for teachers.

Last week we delivered those laptops to them, in the picture our CISO Gijs Roeffen does the handover with Marlies Stoot, Founder JAVEA Nepal

19/10/2021

Download this whitepaper to gain a comprehensive overview of DTx, its regulatory landscape, and routes to commercialization.

http://ow.ly/OXS950Gu53C

14/10/2021

Read this blog discussing why Digital Therapeutics (DTx) companies need to consider data flow for their cybersecurity strategy and give concrete steps to ensure data isn’t compromised.

A robust digital therapeutics cybersecurity system is integral to protecting users’ sensitive information helps meet regulatory requirements and maintain public trust.

07/10/2021

The Castor team is thrilled to see an increasing emphasis on diversity of race, gender, and even geography amongst clinical trial participants. Diversity within trials doesn't just happen—it requires intentional study design. To this end, decentralized clinical trials (DCT) can support and accelerate diversity within clinical research. This article will explore how DCT can successfully address the challenges of maintaining diversity within clinical research.

http://ow.ly/EDSB50GnG36

06/10/2021

📅 Mark your calendars! Fierce Pharma is bringing together an expert panel to explore what digital transformation really means for the HLS industry.
Interested in joining? Register here:

Join this webinar to explore how running a customer-centric organization leads to organisational agility, process efficiency, and ultimately faster speed of innovation.

06/10/2021

Download this eBook to gain a comprehensive overview of eConsent, how it satisfies global regulatory requirements, and critical considerations for ethics board approval.

http://ow.ly/VKJb50Gn5dU

06/10/2021

Thought leaders Derk Arts, MD, Ph.D., Founder & CEO of Castor, and Sam Eells, Co-Founder and Chief Design Officer, Lightship, discuss opportunities to help researchers develop a more successful overall strategy for their patient enrollment. From eRecruitment, pre-screening, and consent, they discuss how anticipating and accommodating patient preferences streamline registration and increase retention. Watch Now!

http://ow.ly/PTgn50GmXMS

05/10/2021

Don't miss the "Advances in Decentralized Trials and Regulatory Considerations" Panel at Global Conference on Regulatory Science 2021 with Panelist Derk Arts, Founder & CEO, Castor

http://ow.ly/ZW2a50GmnUj

, , ,

30/09/2021

Learn the three areas that researchers cite as obstacles when implementing eConsent: data safety; regulatory compliance; and identity verification. And see how these issues can be resolved safely and efficiently. 🔒

Although eConsent struggled to gain momentum and wider acceptance pre-pandemic, it's now a major part of clinical research. In this article, learn three ways eConsent addresses the requirements for valid informed consent.

28/09/2021

Watch Derk Arts, MD PhD and Christian Devonport-McGowan as they examine how Castor used technology to help reduce participant burden and trial timelines by 40% in a recent dermatology trial.

Watch full Video - https://go.marketing.castoredc.com/l/906812/2021-09-28/l61x2s

28/09/2021

Derk Arts, Founder & CEO, Castor will be speaking at Healthcare Leaders webcon Oct 4-5 with biopharma CEOs, Head of FDA, Gov Baker, top academics. Join the meeting here: http://ow.ly/IOiz50GeBes

24/09/2021

Marlon Snik presenting "Benefits of Remote-First on Diversity & Inclusion at Castor" Wednesday, September 29th, 18:00 – 19:30 CET 🤩 🤩

Everyone is welcome to join! Register here:

http://ow.ly/A5mV50GfVoo

We are thrilled that OHT Amsterdam is officially launching! In our first event we will explore the unique opportunities and challenges within the healthtech ecosystem in the Netherlands and how to ensure that equality, diversity and inclusion stay at the core of health innovations.

Adres

Fred. Roeskestraat 115
Amsterdam
1076EE

Website

http://www.castoredc.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Castor EDC nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.